Navigation Links
Data Show Medication Adherence is an Important Factor in the Treatment of Postmenopausal Osteoporosis
Date:9/13/2009

DENVER, Sept. 13 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN) today announced the presentation of data highlighting the links between medication satisfaction, adherence to therapy and fracture risk reduction among women with postmenopausal osteoporosis. The data were presented at the 31st annual meeting of the American Society for Bone Mineral Research (ASBMR).

"These data enhance our understanding of why many women discontinue treatment with current osteoporosis therapies, suggesting that convenience, effectiveness and side effects are important factors," said David Macarios, executive director for Global Health Economics at Amgen. "This new research reinforces the view that poor adherence can lead to negative outcomes including fractures, more frequent hospital admissions and higher medical costs."

Impact of Treatment Satisfaction (Perceived Benefits, Convenience, Side Effects) on Persistence with Postmenopausal Osteoporosis Therapy (Abstract No. SA0317)

Data collected from the Prospective Observational Scientific Study Investigation Bone Loss Experience (POSSIBLE US(TM)) study showed that women who were less satisfied with their osteoporosis therapy were more likely to discontinue or switch their therapy compared to women who were more satisfied.(i) The prospective registry study enrolled 5,015 patients, the majority of whom were using an oral bisphosphonate at the time of study entry, and used the self-administered Treatment Satisfaction Questionnaire for Medication every six months to measure patient satisfaction with convenience, perceived effectiveness and side effects of therapy.

In this study, in which women self-reported their adherence to
'/>"/>

SOURCE Amgen Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Research: Popular Diabetes Medications Associated with Increase in Bone Fractures
2. New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI)
3. VIDEO from Medialink and the Epilepsy Foundation: New Study Suggests Different Versions of the Same Epilepsy Medication Can Be Harmful
4. New Studies Show Popular Heartburn Medications Moderate the Effect of Taking Widely Prescribed Heart Drug
5. Generic Substitutes Less Effective/Safe Than Branded Medications in Treating Lower Urinary Tract Symptoms
6. Addrenex Pharmaceuticals Reports Positive Results in Second Phase 3 Study of ADHD Medication
7. CareHeres Electronic Medication System Proves 100 Percent Effective in Response to Recall
8. American Lung Association Study to be Published in the New England Journal of Medicine Finds Prescription Heartburn Medication Does Not Control Asthma Symptoms as Previously Thought
9. Parkinsons Disease Medication Triggers Destructive Behaviors
10. Aching Back? Cholesterol Medication Might Help
11. Thomson Reuters Study Finds Sharp Increase in Use of Sleep Medications by Young Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... SAN DIEGO , Dec. 17, 2014 ... PHIA) and Volcano Corporation (NASDAQ: VOLC ), a ... applications, today announced that they have entered into a definitive ... tender offer to acquire all of the issued and outstanding ... total equity purchase price of USD 1 billion (approx. EUR ...
(Date:12/17/2014)... HOLBROOK, N.Y. , Dec. 17, 2014 /PRNewswire/ ... that The Depository Trust Company (DTC) has made ... the Deposit Chill on the Company,s stock effective ... of Northstar,s common stock for depository and book ... and the Company is now once again fully ...
(Date:12/17/2014)... 17, 2014  ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE ... Trademark Office (USPTO) has issued a key patent ... immunotherapeutic vaccine targeting six tumor antigens that are ... Patent No. 8,871,211, which issued October 28, 2014, ... a dendritic cell composition comprising peptide epitopes of ...
Breaking Medicine Technology:Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2
... Jan. 22 Protalix,BioTherapeutics, Inc. (Amex: PLX ... concept results in an animal study conducted as ... is being conducted under the agreement the Company ... the technology transfer,arm of the Hebrew University of ...
... approved to reduce both A1C and LDL cholesterol, ... Inc.,announced that the United States Food and Drug ... glycemic control,(measured as hemoglobin A1C) in adults with ... or insulin, either alone or in,combination with other ...
Cached Medicine Technology:Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study 2Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study 3Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 2Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 3Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 4Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 5Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 6Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes 7
(Date:12/21/2014)... December 21, 2014 SCI ... the issues and systemic barriers for disabled athletes with ... Champion. Scheidies has a condition called juvenile macular degeneration, ... describes how he adapted his athletic ambitions to his ... success in triathlon to pioneer the way for other ...
(Date:12/21/2014)... Columbus, OH (PRWEB) December 21, 2014 ... of men alleging heart attacks, stroke and blood clots ... continue to increase, a new study shows that the ... developing colon cancer. In a study published in the ... lead researcher, James Amos-Landgraf examined a group of male ...
(Date:12/21/2014)... CA (PRWEB) December 21, 2014 The Oncology ... drive in the Santa Ana and Whittier offices. The Hope ... brighten the lives of patients and their families during the ... reach out to approximately 70 children between both offices. This ... the help of Target’s community service team, store managers and ...
(Date:12/20/2014)... BambooIndustry.com is a professional company offering many ... recently shown its new engineered bamboo flooring collection, and ... models. , BambooIndustry.com’s customers come from many countries in ... to the CEO of the company, the global bamboo ... past few years, and the demand for eco-friendly bamboo ...
(Date:12/20/2014)... 21, 2014 MissyDress, a distinguished special ... prom lovers. The business has drastically cut prices to ... to everyone until Jan. 30, 2015. Many of the ... dresses, V-neck dresses, lace dresses, and more. , A ... there every day. Whether A-line princess prom dresses or ...
Breaking Medicine News(10 mins):Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4Health News:BammbooIndustry.com: Big Discounts On All Kinds Of Bamboo Flooring Collections 2Health News:MissyDress: The Prices of Prom Dresses Just Reduced 2
... PROVIDENCE, R.I., Sept. 15 Walkers from across southern New ... at 11a.m. on behalf of Hasbro Children,s Hospital at the ... staff and the public are invited to team up to ... in this festive fall fundraiser. Grand Marshall Mayor David N. ...
... , , ... for Healthcare Information Technology (CCHIT(R)) today announced that gloStream,s ... Ambulatory EHR additionally certified for Cardiovascular Medicine and Child ... (EHR) criteria for office-based use. Ambulatory EHRs are designed ...
... , , WASHINGTON , Sept. 15 ... consumers to help them understand a new law requiring insurance ... Wellstone and Pete Domenici Mental Health Parity and Addiction Equity, ... 2010. The law is designed to help improve access ...
... , , ... on Lifesaving Skills , , PITTSBURGH, ... in October, the Sudden Cardiac Arrest Foundation today announced the launch ... on YouTube ( http://www.youtube.com/user/SCAFoundation ). Students from elementary school through ...
... Conn., Sept. 15 Americans have been hearing more about health ... comes to understanding their own health benefits, many may be missing ... Open Enrollment and even save money throughout the year. A survey ... benefits public education program launched in September 2004 by Aetna (NYSE: ...
... studies suggest transmission of virus may last up to a ... with swine flu seem to be contagious longer than patients ... it,s not clear what impact the findings will have on ... the virus continues to produce relatively mild infections in most ...
Cached Medicine News:Health News:Hasbro Children's Hospital Kicks Off Inaugural Fundraising Walk 2Health News:Hasbro Children's Hospital Kicks Off Inaugural Fundraising Walk 3Health News:gloStream's gloEMR Version 5.0 Receives 08 CCHIT Certification 2Health News:gloStream's gloEMR Version 5.0 Receives 08 CCHIT Certification 3Health News:APA Offers Free Resources for Public on Mental Health Parity Law 2Health News:Sudden Cardiac Arrest Foundation Kicks Off 'You Can Save A Life' Video Awareness Contest on YouTube(TM) 2Health News:Sudden Cardiac Arrest Foundation Kicks Off 'You Can Save A Life' Video Awareness Contest on YouTube(TM) 3Health News:Consumers Overlooking Opportunities at Open Enrollment May be Missing Out 2Health News:Consumers Overlooking Opportunities at Open Enrollment May be Missing Out 3Health News:Consumers Overlooking Opportunities at Open Enrollment May be Missing Out 4Health News:Consumers Overlooking Opportunities at Open Enrollment May be Missing Out 5Health News:Consumers Overlooking Opportunities at Open Enrollment May be Missing Out 6Health News:People With Swine Flu May Be Contagious Longer Than Thought 2Health News:People With Swine Flu May Be Contagious Longer Than Thought 3
The Rapidpoint 400/405 instrument is a point-of-care blood gas analyzer that's fast, easy to operate and reliable....
... The AVOXimeter 4000 provides a fast, ... bedside. The AVOXimeters patented,state-of-the-art optics yield ... as well as total hemoglobin. When,used ... analyzer, the AVOXimeter,4000 gives a comprehensive ...
... diagnostic accuracy for appropriate treatment options , ... used to inject fluid into the intervertebral ... will measure the pressure of the fluid ... The physician can control the pressure of ...
The GEM OPL CO-Oximeter provides comprehensive oxygenation status in an easy-to-use, portable manner. The GEM OPL is the ideal solution for laboratory or point-of-care CO-Oximetry testing....
Medicine Products: